These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10938460)

  • 1. Mechanism of action in a 4,5-diarylpyrrole series of selective cyclo-oxygenase-2 inhibitors.
    Zoete V; Maglia F; Rougée M; Bensasson RV
    Free Radic Biol Med; 2000 Jun; 28(11):1638-41. PubMed ID: 10938460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a new class of selective cyclooxygenase-2 (COX-2) inhibitor that covalently modifies the isozyme.
    Kalgutkar AS; Crews BC; Rowlinson SW; Garner C; Marnett LJ
    Adv Exp Med Biol; 1999; 469():139-43. PubMed ID: 10667322
    [No Abstract]   [Full Text] [Related]  

  • 3. 1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2.
    Khanna IK; Weier RM; Yu Y; Collins PW; Miyashiro JM; Koboldt CM; Veenhuizen AW; Currie JL; Seibert K; Isakson PC
    J Med Chem; 1997 May; 40(11):1619-33. PubMed ID: 9171872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Aryl/cycloalkyl-5-phenyloxazole derivatives as selective COX-2 inhibitors.
    Hashimoto H; Maeda K; Ozawa K; Haruta J; Wakitani K
    Bioorg Med Chem Lett; 2002 Jan; 12(1):65-8. PubMed ID: 11738574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors.
    Kalgutkar AS; Rowlinson SW; Crews BC; Marnett LJ
    Bioorg Med Chem Lett; 2002 Feb; 12(4):521-4. PubMed ID: 11844663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human and rat cyclooxygenases are pharmacologically distinct.
    Ramesha CS
    Adv Exp Med Biol; 1997; 407():67-71. PubMed ID: 9321933
    [No Abstract]   [Full Text] [Related]  

  • 7. The pyrrole moiety as a template for COX-1/COX-2 inhibitors.
    Dannhardt G; Kiefer W; Krämer G; Maehrlein S; Nowe U; Fiebich B
    Eur J Med Chem; 2000 May; 35(5):499-510. PubMed ID: 10889329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclo-oxygenase isoenzymes: physiological and pharmacological role.
    Kam PC; See AU
    Anaesthesia; 2000 May; 55(5):442-9. PubMed ID: 10792135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase.
    Rioja I; Terencio MC; Ubeda A; Molina P; Tárraga A; Gonzalez-Tejero A; Alcaraz MJ
    Eur J Pharmacol; 2002 Jan; 434(3):177-85. PubMed ID: 11779581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-1/COX-2 inhibitors based on the methanone moiety.
    Dannhardt G; Fiebich BL; Schweppenhäuser J
    Eur J Med Chem; 2002 Feb; 37(2):147-61. PubMed ID: 11858847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2 selectivity and inflammatory processes.
    van Ryn J; Trummlitz G; Pairet M
    Curr Med Chem; 2000 Nov; 7(11):1145-61. PubMed ID: 11032964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL
    Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of cyclooxygenase-2 inhibition by indanone derivatives.
    Klein T; Nüsing RM
    Adv Exp Med Biol; 1997; 407():503-7. PubMed ID: 9321998
    [No Abstract]   [Full Text] [Related]  

  • 14. A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors.
    Li CS; Black WC; Brideau C; Chan CC; Charleson S; Cromlish WA; Claveau D; Gauthier JY; Gordon R; Greig G; Grimm E; Guay J; Lau CK; Riendeau D; Thérien M; Visco DM; Wong E; Xu L; Prasit P
    Bioorg Med Chem Lett; 1999 Nov; 9(22):3181-6. PubMed ID: 10576684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclooxygenase (COX) enzymes by compounds from Daucus carota L. Seeds.
    Momin RA; De Witt DL; Nair MG
    Phytother Res; 2003 Sep; 17(8):976-9. PubMed ID: 13680840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of NSAID therapy: selective COX-2 inhibitors.
    Vane JR; Botting RM
    Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 1,3,4-triaryl-3-pyrrolin-2-ones, a new class of selective cyclooxygenase-2 inhibitors.
    Bosch J; Roca T; Catena JL; Llorens O; Pérez JJ; Lagunas C; Fernández AG; Miquel I; Fernández-Serrat A; Farrerons C
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1745-8. PubMed ID: 10937738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,5-Diarylpyrrole-3-acetic acids and esters as novel classes of potent and highly selective cyclooxygenase-2 inhibitors.
    Biava M; Porretta GC; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Makovec F; Anzini M
    J Med Chem; 2005 May; 48(9):3428-32. PubMed ID: 15857149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of the dynamic mechanism of ligand binding to cyclooxygenase.
    Llorens O; Perez JJ; Palomer A; Mauleon D
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2779-84. PubMed ID: 10522690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectral and crystallographic study of pyridinic analogues of nimesulide: determination of the active form of methanesulfonamides as COX-2 selective inhibitors.
    Julémont F; de Leval X; Michaux C; Damas J; Charlier C; Durant F; Pirotte B; Dogné JM
    J Med Chem; 2002 Nov; 45(23):5182-5. PubMed ID: 12408728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.